Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

review · 2015

Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure

Results of phase I and phase II studies demonstrate that omecamtiv mecarbil is safe and well tolerated both as an intravenous and oral formulation. In health...

46 citationsDOI: https://doi.org/10.1517/13543784.2016.1123248
Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure